SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Astute Medical Inc. today announced that it has received clearance from the Food and Drug Administration to commence sales of its first biomarker-based immunoassay, NephroCheck.
San Diego--based ResMed Inc. and APEX Medical Corp. have agreed to a confidential settlement resolving their outstanding patent disputes.
Biotech: The Device Is a Less Expensive Solution For Incurable Skin Disorders
Martyn Gross has suffered from psoriasis for most of his life, particularly on the difficult-to-treat regions of the hand and feet. After years of trying costly and ineffective treatments from uncomfortable phototherapy sessions in cold medical facilities to topical creams that wash off too easily, Gross decided to develop a handheld light therapy device to treat himself at home.
HEALTH: Sequencing and Analytics Part of Process
Recent trends in biotech research point to faster, more efficient and less costly drug development for pharmaceutical companies.
San Diego-based Ajinomoto Althea Inc., a biopharmaceutical contract development and manufacturing company, has received clearance to test its commercial drug products for the European market.
Mirati Therapeutics Inc. announced that the first patient has been dosed in its phase one clinical study for the treatment of patients with advanced solid tumors.
Halozyme Therapeutics Inc. announced that the Food and Drug Administration has granted Fast Track designation for its program investigating a treatment for patients with metastatic pancreatic cancer.
RuiYi Inc. announced today the appointment of Mark Saad as chief financial officer.
San Diego-based BioLegend Inc. acquired the shares of Covance Antibody Services Inc., a business unit of Massachusetts-based Covance Inc., on August 29.
Arena Pharmaceuticals Inc. announced that the Food and Drug Administration has granted orphan drug status to the company’s drug candidate for the treatment of pulmonary arterial hypertension.
HEALTH: Govt. Would Get Veto Power on Rate Increases
Health insurance companies may suffer a caustic blow by a currently popular ballot initiative that would expand the state’s authority to regulate health insurance rates.
San Diego-based Seragon Pharmaceuticals Inc. today announced the closing of its acquisition by Genentech Inc., a member of the Roche Group.
The elusive CEO of Mapp Biopharmaceutical Inc., the company that delivered an experimental Ebola drug to American aid workers in West Africa, spoke at a panel discussion yesterday afternoon hosted by The Scripps Research Institute.
San Diego-based Tocagen Inc. announced Wayne Saville has been named vice president of clinical development and Mary Rose Keller has been named vice president of clinical operations.